Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over accusations that it artificially inflated the prices of insulin drugs, violating ...

Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — without affecting Express Scripts’ profitability.

Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers.

By Jody Godoy Feb 4 (Reuters) - Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and ...

Cigna and Express Scripts are planning a merger for several reasons, one of them being “the potential entry into the healthcare industry of significant new participants,” according to a May 16 ...

Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and stock, including assumption of $15 billion in Express Scripts debt. Here are five things to know about the ...

“Together with Express Scripts, Cigna will further accelerate our strategy of Go Deeper, Go Local and Go Beyond by improving affordability and choice, expanding our distribution reach, and further ...

"The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other [pharmacy benefit managers]," said Andrea Nelson, Cigna Group's chief ...

Cigna, one of the US largest health insurers, announced the deal in March, offering $48.75 a share in cash for Express Scripts in a move aimed to cut soaring healthcare costs. The $54 billion price ...

Cigna's pharmacy benefit manager Express Scripts has filed a lawsuit against the FTC over the agency's recent report on PBMs, which highlighted their contribution to soaring drug prices in the U.S.